Hologic finalizes acquisition of DRCBone densitometer firm Hologic has completed its purchase of Direct Radiography from SDI Holding, the parent company of Agfa subsidiary Sterling Diagnostic Imaging. The deal was valued at about $20 million,
Bone densitometer firm Hologic has completed its purchase of Direct Radiography from SDI Holding, the parent company of Agfa subsidiary Sterling Diagnostic Imaging. The deal was valued at about $20 million, consisting of $7 million in cash and around 1.9 million shares of Hologic common stock. The purchase amount decreased sharply from the initial agreement, which was valued at about $30 million.
Hologic was able to get some price concessions in exchange for a speedy closing, said David Ellenbogen, Hologic chairman and CEO.
As a result of the acquisition, Hologic receives about 90 employees, a 168,000-square-foot research, development, manufacturing, and administrative site in Newark, DE, and 26 U.S. patents, as well as a number of foreign ones.
Hologic plans to market DRCs DirectRay digital radiography technology via a number of channels, including OEM opportunities. Discussions with several potential OEM clients are under way, Ellenbogen said.
The company also will participate in the retrofit sector, equipping recently purchased traditional x-ray rooms with its DirectRay detectors to pave the way for PACS, he said. In addition to the firms first retrofit site at Brooke Army Medical Center in Fort Sam Houston, TX, (PNN 2/99), DRC has installed a retrofit at an undisclosed location.
Finally, Bedford, MA-based Hologic will continue DRCs direct sales efforts with its traditional iiRAD systems. In future development plans, Hologic expects to bring DirectRay technology suitable for fluoroscopy and mammography applications to market. Commercialization of these products would not occur for at least a year, however, Ellenbogen said.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.
Study Examines CT-Based AI Detection of Incidental Abdominal Aortic Aneurysms
April 29th 2025The AI software Viz AAA offered a sensitivity of 87.5 percent in detecting abdominal aortic aneurysms on contrast-enhanced CT, according to new retrospective research presented at the American Roentgen Ray Society (ARRS) conference.